UniProt Q6GMX6
Trastuzumab Fab heavy chain (Q6GMX6)
Trastuzumab Fab heavy chain (UniProt Q6GMX6): 25 experimental structures on GenesisL1, 1 ligand bound, 4 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q6GMX6
- Protein
- Trastuzumab Fab heavy chain
- Experimental structures
- 25
- Predicted models
- 0
- Ligands
- 1
- Pockets
- 4 · 1 record with a druggable one
Structures
25 records of Q6GMX6 in the MolNFT archive: 25 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1ZA6 | The structure of an antitumor CH2-domain-deleted humanized antibody | x-ray diffraction | B, D, F, H | — | — |
| 1ZA6 | The structure of an antitumor CH2-domain-deleted humanized antibody | x-ray diffraction | B, D, F, H | — | — |
| 4D9L | Fab structure of anti-HIV-1 gp120 V2 mAb 697 | x-ray diffraction | H, I, J, K | — | — |
| 4D9L | Fab structure of anti-HIV-1 GP120 V2 mab 697 | x-ray diffraction | H, I, J, K | — | — |
| 5O1R | human Fab 5H2 bound to NHBA-C3 from Neisseria meningitidis serogroup B | x-ray diffraction | H, I | — | — |
| 5O1R | Human Fab 5H2 bound to nhba-C3 from neisseria meningitidis serogroup B | x-ray diffraction | H, I | — | — |
| 5UTZ | Human il-2/FAB complex | x-ray diffraction | H, B, F, J | — | — |
| 5VR9 | CH1/CKAPPA Fab based on matuzumab | x-ray diffraction | A, H | — | — |
| 5VSI | CH1/Ckappa Fab mutant 15.1 | x-ray diffraction | H | SO4 | — |
| 5VSI | CH1/CKAPPA Fab mutant 15.1 | x-ray diffraction | H | SO4 | — |
| 6AL4 | Crystal structure of anti-CD19 antibody B43 Fab | x-ray diffraction | B, D, F | — | — |
| 6APD | Crystal structure of RSV F bound by AM22 and the infant antibody ADI-19425 | x-ray diffraction | D, F, H | — | — |
| 6APD | Crystal structure of rsv F bound by AM22 and the infant antibody adi- 19425 | x-ray diffraction | D, F, H | — | — |
| 6B9Y | Trastuzumab Fab v3 in complex with 5-phenyl meditope variant | x-ray diffraction | B | — | 4 (best 0.61) |
| 6B9Y | Trastuzumab Fab V3 in complex with 5-phenyl meditope variant | x-ray diffraction | B | — | — |
| 6BAH | Trastuzumab Fab V3 with 5-diphenyl meditope variant | x-ray diffraction | B | — | — |
| 6DC4 | Rsv-neutralizing human antibody AM22 | x-ray diffraction | H | — | — |
| 6DC5 | Rsv prefusion F in complex with AM22 Fab | x-ray diffraction | B, E, H | — | — |
| 6OGE | Cryo-EM structure of HER2 extracellular domain-trastuzumab Fab- pertuzumab Fab complex | electron microscopy | E | — | — |
| 6VPY | I33M (I3.2 mutant from CH103 lineage) | x-ray diffraction | A, H | — | — |
| 7CZR | S protein of SARS-cov-2 in complex bound with P5A-1B8_2B | electron microscopy | H, J | — | — |
| 7CZS | S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B | electron microscopy | H, I, J | — | — |
| 7CZS | S protein of SARS-cov-2 in complex bound with P5A-1B8_3B | electron microscopy | H, I, J | — | — |
| 7CZX | S protein of SARS-cov-2 in complex bound with P5A-1B9 | electron microscopy | H, I, J | — | — |
| 7D00 | S protein of SARS-cov-2 in complex bound with FABP5A-1B8 | electron microscopy | H, J | — | — |
Ligands
- SO4 · Sulfate ion · in 2 records
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.